Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo

Cited 19 time in scopus
Metadata Downloads
Title
Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo
Author(s)
J Y Kim; Hyun-Mee Oh; S C Kwak; Y H Cheon; M S Lee; Mun Chual Rho; J Oh
Bibliographic Citation
Biological & Pharmaceutical Bulletin, vol. 38, no. 1, pp. 66-74
Publication Year
2015
Abstract
Akt/GSK3β-c-Fos-NFATc1 signaling cascades. Therefore, purslane is a potential natural medicine for the treatment of osteoclast-related diseases.
Keyword
Bone lossNatural medicineOsteoclastOsteoporosisPurslane (Portulaca oleracea)
ISSN
0918-6158
Publisher
Pharmaceutical Soc Japan
DOI
http://dx.doi.org/10.1248/bpb.b14-00567
Type
Article
Appears in Collections:
Jeonbuk Branch Institute > Immunoregulatory materials Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.